Skip to main content
QDEL
NASDAQ Life Sciences

QuidelOrtho Reports In-Line Q4/FY25 Results, Projects Strong FY26 Growth & Free Cash Flow Turnaround

Analysis by Wiseek AI
Sentiment info
Positive
Importance info
7
Price
$28.8
Mkt Cap
$1.956B
52W Low
$19.5
52W High
$43.92
Market data snapshot near publication time

Summary

QuidelOrtho reported Q4 and full-year 2025 results that met guidance for key non-GAAP metrics, while also providing strong fiscal year 2026 guidance, including a significant projected improvement in free cash flow. The company also announced the planned retirement of its CFO.


Key Events

  • Q4 and Full-Year 2025 Financial Results

    QuidelOrtho reported full-year 2025 total revenue of $2.73 billion, adjusted EBITDA of $597 million, and adjusted diluted EPS of $2.12, all within previously issued guidance ranges. The company recorded a GAAP net loss of $1.13 billion, which included a $701 million non-cash goodwill impairment charge. Free cash flow for FY25 was negative $77 million, impacted by one-time ERP system conversion investments.

  • Strong FY2026 Financial Guidance

    The company provided fiscal year 2026 guidance, projecting total revenues between $2.7 billion and $2.9 billion, adjusted EBITDA of $630 million to $670 million, and adjusted diluted EPS of $2.00 to $2.42. Notably, free cash flow is expected to significantly improve to $120 million to $160 million, marking a substantial turnaround from the prior year.

  • CFO Joseph M. Busky to Retire

    Joseph M. Busky, Chief Financial Officer, announced his decision to retire effective June 30, 2026. The company has initiated a search for his successor, and Mr. Busky will serve in an advisory role to ensure a smooth transition.


Analysis

QuidelOrtho Corp announced financial results for Q4 and full-year 2025, meeting its guidance for key non-GAAP metrics such as total revenue, adjusted EBITDA, and adjusted diluted EPS. While the company reported a significant GAAP net loss for the full year, this included a substantial non-cash goodwill impairment charge. More importantly, the company provided robust financial guidance for fiscal year 2026, projecting growth in total revenues, adjusted EBITDA, and a significant turnaround in free cash flow from a negative $77 million in FY25 to a positive $120-$160 million. This strong forward-looking guidance, particularly the free cash flow improvement, signals a healthier financial trajectory for the company. Additionally, the company announced the planned retirement of its CFO, Joseph M. Busky, effective June 30, 2026, with a search for a successor underway and a smooth transition planned.

At the time of this filing, QDEL was trading at $28.80 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2B. The 52-week trading range was $19.50 to $43.92. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

QDEL - Latest Insights

QDEL
May 05, 2026, 5:46 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $11.55
Real-time Price: $14.13 info
Change: +$2.58 (+22%) info
Market Cap: $963.539M info
QDEL
May 05, 2026, 4:47 PM EDT
Source: Reuters
Importance Score:
9
Price at Filing: $11.49
Real-time Price: $14.13 info
Change: +$2.64 (+23%) info
Market Cap: $963.539M info
QDEL
May 05, 2026, 4:07 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $11.52
Real-time Price: $14.13 info
Change: +$2.61 (+23%) info
Market Cap: $963.539M info
QDEL
Apr 27, 2026, 4:05 PM EDT
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $12.29
Real-time Price: $14.13 info
Change: +$1.84 (+15%) info
Market Cap: $963.539M info
QDEL
Apr 20, 2026, 7:12 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $12.41
Real-time Price: $14.13 info
Change: +$1.73 (+14%) info
Market Cap: $963.539M info
QDEL
Apr 16, 2026, 11:42 AM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $11.98
Real-time Price: $14.13 info
Change: +$2.16 (+18%) info
Market Cap: $963.539M info
QDEL
Apr 15, 2026, 4:18 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $16.98
Real-time Price: $14.13 info
Change: -$2.85 (-17%) info
Market Cap: $963.539M info
QDEL
Apr 15, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $14.00
Real-time Price: $14.13 info
Change: +$0.131 (+0.94%) info
Market Cap: $963.539M info
QDEL
Mar 24, 2026, 7:00 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $15.99
Real-time Price: $14.13 info
Change: -$1.86 (-12%) info
Market Cap: $963.539M info
QDEL
Feb 18, 2026, 9:45 PM EST
Filing Type: 10-K
Importance Score:
9
Price at Filing: $24.16
Real-time Price: $14.13 info
Change: -$10.03 (-42%) info
Market Cap: $963.539M info